Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ARS PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 304,445 shares of SPRY (ARS PHARMACEUTICALS INC), worth $3.5M as of 2025-Q4. The position was decreased (-9.2% shares). SPRY represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$3.5M
Current Shares
304,445
Total Value Change
+$3.3M
Total Shares Change
+277,364
Other major holders of SPRY: RA CAPITAL MANAGEMENT, L.P.
Decreased |
| 304,445 |
-9.2% |
| $3.5M |
| 0.0% |
| $11.64 |
0 |
| 2025-Q3 | Increased | 335,148 | +2.9% | $3.4M | 0.0% | $9.72 | 27 |
| 2025-Q2 | Increased | 325,645 | +16.4% | $5.7M | 0.0% | $18.20 | 31 |
| 2025-Q1 | Increased | 279,840 | +13.2% | $3.5M | 0.0% | $12.49 | 30 |
| 2024-Q4 | Increased | 247,314 | +5.5% | $2.6M | 0.0% | $10.62 | 28 |
| 2024-Q3 | Increased | 234,537 | +766.1% | $3.4M | 0.0% | $14.32 | 43 |
| 2024-Q2 | Increased | 27,081 | +109.3% | $230,459 | 0.0% | $8.51 | 37 |